ProfileGDS4718 / 235764_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 12% 9% 61% 19% 11% 33% 26% 13% 14% 20% 15% 2% 7% 21% 1% 23% 27% 4% 28% 7% 16% 23% 25% 16% 32% 19% 19% 13% 18% 23% 8% 37% 4% 6% 15% 53% 3% 13% 6% 64% 19% 16% 25% 23% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.8762612
GSM549102patient 115, normal, homogenized [OPG study]3.763979
GSM549104patient 119, normal, homogenized [OPG study]6.2454161
GSM549108patient 138, normal, homogenized [OPG study]4.1331219
GSM549119patient 077, normal, homogenized [OPG study]3.8197711
GSM549133patient 032, cancer, homogenized [OPG study]4.6032233
GSM549139patient 042, cancer, homogenized [OPG study]4.3764226
GSM549099patient 107, normal, homogenized [OPG study]3.9000113
GSM549109patient 139, normal, homogenized [OPG study]3.9647914
GSM549110patient 046, normal, homogenized [OPG study]4.1623920
GSM549114patient 063, normal, homogenized [OPG study]3.948215
GSM549122patient 082, normal, homogenized [OPG study]3.457772
GSM549134patient 033, cancer, homogenized [OPG study]3.662917
GSM549136patient 036, cancer, homogenized [OPG study]4.1350421
GSM549140patient 044, cancer, homogenized [OPG study]3.289121
GSM549111patient 047, normal, homogenized [OPG study]4.2398423
GSM549113patient 057, normal, homogenized [OPG study]4.3704927
GSM549132patient 031, cancer, homogenized [OPG study]3.553694
GSM549137patient 038, cancer, homogenized [OPG study]4.4389328
GSM549142patient 047, cancer, homogenized [OPG study]3.716757
GSM549100patient 110, normal, homogenized [OPG study]4.0019716
GSM549107patient 135, normal, homogenized [OPG study]4.2389423
GSM549115patient 068, normal, homogenized [OPG study]4.2956925
GSM549116patient 072, normal, homogenized [OPG study]3.9745416
GSM549120patient 078, normal, homogenized [OPG study]4.6282132
GSM549131patient 030, cancer, homogenized [OPG study]4.0487319
GSM549118patient 074, normal, homogenized [OPG study]4.1328619
GSM549129patient 027, cancer, homogenized [OPG study]3.9115413
GSM549123patient 088, normal, homogenized [OPG study]4.0795218
GSM549124patient 006, cancer, homogenized [OPG study]4.2859123
GSM549126patient 015, cancer, homogenized [OPG study]3.682928
GSM549128patient 025, cancer, homogenized [OPG study]4.8331837
GSM549103patient 117, normal, homogenized [OPG study]3.536984
GSM549117patient 073, normal, homogenized [OPG study]3.627166
GSM549138patient 041, cancer, homogenized [OPG study]3.9354515
GSM549141patient 045, cancer, homogenized [OPG study]5.6401353
GSM549130patient 028, cancer, homogenized [OPG study]3.513413
GSM549101patient 111, normal, homogenized [OPG study]3.8796713
GSM549105patient 128, normal, homogenized [OPG study]3.641416
GSM549106patient 134, normal, homogenized [OPG study]6.3818864
GSM549112patient 048, normal, homogenized [OPG study]4.11919
GSM549125patient 011, cancer, homogenized [OPG study]3.9967216
GSM549127patient 024, cancer, homogenized [OPG study]4.3073825
GSM549135patient 035, cancer, homogenized [OPG study]4.219623